Company Financials

Guardant Health, Inc. Financials

United States dollar

business Guardant Health, Inc. Company Profile

Main Stock Listing

NASDAQ: GH

Market Capitalization $13.21 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -28.58
Forward PE -70.61
Price to Sales TTM $14.64
Price to Book MRQ $-35.82
Enterprise to Revenue 15.04
Enterprise to EBITDA -33.74

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -44.18%
Operating Margin -37.28%
Return on Assets TTM -19.64%
Return on Equity TTM 312.48%

Income Statement

Revenue TTM $902,569,024
Revenue per Share TTM $7.27
Quarterly Revenue Growth 38.50%
Gross Profit TTM $575,460,992
EBITDA $-402,192,992
Net Income to Common TTM $-398,788,992
Diluted EPS TTM $-3.21
Quarterly Earnings Growth YoY 38.50%

Balance Sheet

Total Cash MRQ $580,012,992
Total Cash per Share MRQ $4.60
Total Debt MRQ $
Total Debt to Equity MRQ -3.74
Current Ratio MRQ 3.50
Book Value per Share MRQ $-2.84

Cash Flow

Operating Cash Flow TTM $-222,900,000
Levered Free Cash Flow TTM $-24,376,376

GH Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 125,005,715
Float Shares 121,013,310
Avg 10 Volume 1,499,590
Avg 30 Volume None
Shares Short 9,851,197
Short Ratio 4.36
Short % of Shares 7.95%
% Held by Insiders 4.07%
% Held by Institutions 97.36%

Stock Price Summary

Beta 1.59
Fifty Two Week Low $33.75
Fifty Two Week High $112.43
Fifty Two Week Change 64.73%
Day 50 MA $96.50
Day 200 MA $62.13

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date